Home Other Building Blocks 223652-90-2
223652-90-2,MFCD12031996
Catalog No.:AA00BF38

223652-90-2 | Garenoxacin mesylate hydrate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%(HPLC)
in stock  
$123.00   $86.00
- +
10mg
98%(HPLC)
in stock  
$167.00   $117.00
- +
25mg
98%(HPLC)
in stock  
$289.00   $203.00
- +
50mg
98%(HPLC)
in stock  
$458.00   $320.00
- +
100mg
98%(HPLC)
in stock  
$737.00   $516.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00BF38
Chemical Name:
Garenoxacin mesylate hydrate
CAS Number:
223652-90-2
Molecular Formula:
C24H26F2N2O8S
Molecular Weight:
540.5336
MDL Number:
MFCD12031996
SMILES:
CS(=O)(=O)O.FC(Oc1c(ccc2c1n(cc(c2=O)C(=O)O)C1CC1)c1ccc2c(c1)CN[C@@H]2C)F.O
Properties
Computed Properties
 
Complexity:
863  
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
5  

Literature

Title: Effect of trace amounts of water in the mobile phase of normal-phase enantioselective high-performance liquid chromatography on selectivity and resolution of optical isomers.

Journal: Journal of chromatographic science 20090401

Title: Advances in DNA gyrase inhibitors.

Journal: Expert opinion on investigational drugs 20010201

Title: In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.

Journal: Antimicrobial agents and chemotherapy 19990501

Title: Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5.

Title: Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80.

Title: Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 223652-90-2
Tags:223652-90-2 Molecular Formula|223652-90-2 MDL|223652-90-2 SMILES|223652-90-2 Garenoxacin mesylate hydrate